Results 261 to 270 of about 1,649,588 (336)

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

British Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt, Áine Keogh, Linda Duane, John Ferguson, Anna Hobbins, Brian E. McGuire, Patrick Gillespie, Laurence J. Egan   +7 more
wiley   +1 more source

An evaluation of the impacts of health insurance coverage on wealth stratification in some selected sub-Saharan countries. [PDF]

Health Econ Rev
Malik AA, Kaplan M.
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

British Journal of Clinical Pharmacology, EarlyView.
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez, Gülnihal Özcan, Hakan S. Orer   +2 more
wiley   +1 more source

Implications of Data Extraction and Processing of Electronic Health Records for Epidemiological Research: Observational Study.

J Med Internet Res
van Essen MHJ, Twickler R, Weesie YM, Arslan IG, Groenhof F, Peters LL, Bos I, Verheij RA.   +7 more
europepmc   +1 more source

Equity of Continuous Glucose Monitoring in Children and Young People With Type 1 Diabetes: A Systematic Review. [PDF]

Pediatr Diabetes
Howard Dicks J, McCann LJ, Tolley A, Barrell A, Johnson L, Kuhn I, Ford J.   +6 more
europepmc   +1 more source

Talk at Desjardins General Insurance

, 2011
openaire   +2 more sources

Electronic medicine management systems in developing countries: A landscape review

British Journal of Clinical Pharmacology, EarlyView.
Medicines are a major global health expense. However, suboptimal use increases costs and causes patient harm. One way to reduce costs and increase safe, efficient medicines use is with electronic medicines management systems (EMMS). They allow easy capture of routine health data which can facilitate research, service planning and reimbursement ...
Andrew Lambarth, Dalia Wainwright, Trisha Saha, Millicent Banks, Iona Minty, P.A.M.K. Abeywickrama, Reya V. Shah, Yogini Jani, Reecha Sofat   +8 more
wiley   +1 more source

Determinants of medical costs in patients with and without fractures using Korean Senior Cohort Study. [PDF]

Sci Rep
Chae K, Kim DS.
europepmc   +1 more source

How digital health literacy shapes health: Mediating role of physical activity and heterogeneity in China. [PDF]

PLoS One
Cheng W, Miao M, Jiao L, Liu X.
europepmc   +1 more source